REFERENCES
- Piret J, Boivin G. Clinical development of letermovir and maribavir:
Overview of human cytomegalovirus drug resistance. Antiviral
Res. 2019;163:91-105. doi: 10.1016/j.antiviral.2019.01.011.
- Marty FM, Ljungman P, Chemaly RF, et al. Letermovir Prophylaxis for
Cytomegalovirus in Hematopoietic-Cell Transplantation. N Engl J
Med . 2017;377(25):2433-2444. doi: 10.1056/NEJMoa1706640.
- Cassaniti I, Colombo AA, Bernasconi P, et al. Positive HCMV DNAemia in
stem cell recipients undergoing letermovir prophylaxis is expression
of abortive infection. Am J Transplant . 2021; 21(4):1622-1628.
doi: 10.1111/ajt.16450.
- Tong Y, Pang XL, Mabilangan C, et al. Determination of the Biological
Form of Human Cytomegalovirus DNA in the Plasma of Solid-Organ
Transplant Recipients. J Infect Dis . 2017; 215(7):1094-1101.
doi: 10.1093/infdis/jix069.
- Gerna G, Baldanti F, Lilleri D, et al. Human cytomegalovirus pp67
mRNAemia versus pp65 antigenemia for guiding preemptive therapy in
heart and lung transplant recipients: a prospective, randomized,
controlled, open-label trial. Transplantation .
2003;75(7):1012-1019. doi: 10.1097/01.TP.0000057239.32192.B9.
- Gerna G, Lilleri D, Baldanti F, et al. Human cytomegalovirus
immediate-early mRNAemia versus pp65 antigenemia for guiding
pre-emptive therapy in children and young adults undergoing
hematopoietic stem cell transplantation: a prospective, randomized,
open-label trial. Blood . 2003;101(12):5053-5060. doi:
10.1182/blood-2002-12-3636.
- Lehto JT, Lemström K, Halme M, et al A prospective study comparing
cytomegalovirus antigenemia, DNAemia and RNAemia tests in guiding
pre-emptive therapy in thoracic organ transplant recipients.Transpl Int . 2005;18(12):1318-1327. doi:
10.1111/j.1432-2277.2005.00226.x.
- Terhune SS, Schröer J, Shenk T. RNAs are packaged into human
cytomegalovirus virions in proportion to their intracellular
concentration. J Virol . 2004;78(19):10390-10398. doi:
10.1128/JVI.78.19.10390-10398.2004.
- Gerna G, Vitulo P, Rovida F, et al. Impact of human metapneumovirus
and human cytomegalovirus versus other respiratory viruses on the
lower respiratory tract infections of lung transplant recipients.J Med Virol . 2006;78(3):408-416. doi: 10.1002/jmv.20555.
Erratum in: J Med Virol . 2008;80(10):1869.
- Furione M, Rognoni V, Cabano E, et al. Kinetics of human
cytomegalovirus (HCMV) DNAemia in transplanted patients expressed in
international units as determined with the Abbott RealTime CMV assay
and an in-house assay. J Clin Virol . 2012;55(4):317-322. doi:
10.1016/j.jcv.2012.08.017.
- Wu Z, Ren X, Yang L, et al. Virome analysis for identification of
novel mammalian viruses in bat species from Chinese provinces. J
Virol . 2012;86(20):10999-11012. doi: 10.1128/JVI.01394-12.
- Gerna G, Revello MG, Percivalle E, et al. Quantification of human
cytomegalovirus viremia by using monoclonal antibodies to different
viral proteins. J Clin Microbiol 1990;28: 2681-8.
- Gerna G, Zavattoni M, Baldanti F, et al. Human cytomegalovirus (HCMV)
leukodnaemia correlates more closely with clinical symptoms than
antigenemia and viremia in heart and heart-lung transplant recipients
with primary HCMV infection. Transplantation .
1998;65(10):1378-85. doi: 10.1097/00007890-199805270-00016.
- Gerna G, Lilleri D, Zecca M, et al. Rising antigenemia levels may be
misleading in pre-emptive therapy of human cytomegalovirus infection
in allogeneic hematopoietic stem cell transplant recipients.Haematologica . 2005;90(4):526-533.
- Baldanti F, Lilleri D, Gerna G. Monitoring human cytomegalovirus
infection in transplant recipients. J Clin Virol .
2008;41(3):237-241. doi: 10.1016/j.jcv.2007.12.001.
- Kotton CN, Kumar D, Caliendo AM, et al; The Transplantation Society
International CMV Consensus Group. The Third International Consensus
Guidelines on the Management of Cytomegalovirus in Solid-organ
Transplantation. Transplantation . 2018;102(6):900-931. doi:
10.1097/TP.0000000000002191.
- Gerna G, Sarasini A, Lilleri D, et al. In vitro model for the study of
the dissociation of increasing antigenemia and decreasing DNAemia and
viremia during treatment of human cytomegalovirus infection with
ganciclovir in transplant recipients. J Infect Dis .
2003;188(11):1639-1647. doi: 10.1086/379376.
- Chou S, Satterwhite LE, Ercolani RJ. New Locus of Drug Resistance in
the Human Cytomegalovirus UL56 Gene Revealed by In Vitro Exposure to
Letermovir and Ganciclovir. Antimicrob Agents Chemother.
2018;62(9):e00922-18. doi: 10.1128/AAC.00922-18.
- Biron KK, Harvey RJ, Chamberlain SC, et al. Potent and selective
inhibition of human cytomegalovirus replication by 1263W94, a
benzimidazole L-riboside with a unique mode of action.Antimicrob Agents Chemother . 2002;46(8):2365-2372. doi:
10.1128/AAC.46.8.2365-2372.2002.
- Maertens J, Cordonnier C, Jaksch P, et al. Maribavir for Preemptive
Treatment of Cytomegalovirus Reactivation. N Engl J Med .
2019(12);381:1136-1147. doi: 10.1056/NEJMoa1714656.
- Bresnahan WA, Shenk T. A subset of viral transcripts packaged within
human cytomegalovirus particles. Science .
2000;288(5475):2373-2376. doi: 10.1126/science.288.5475.2373
- Greijer AE, Dekkers CA, Middeldorp JM. Human cytomegalovirus virions
differentially incorporate viral and host cell RNA during the assembly
process. J Virol . 2000;74(19):9078-9082. doi:
10.1128/jvi.74.19.9078-9082.2000.
- Sarcinella E, Brown M, Tellier R, et al. Detection of RNA in purified
cytomegalovirus virions. Virus Res . 2004;104(2):129-137. doi:
10.1016/j.virusres.2004.03.008.
- Sciortino MT, Suzuki M, Taddeo B, et al. RNAs extracted from herpes
simplex virus 1 virions: apparent selectivity of viral but not
cellular RNAs packaged in virions. J Virol .
2001;75(17):8105-8116. doi: 10.1128/jvi.75.17.8105-8116.2001.
- Boriskin YS, Fuller K, Powles RL, et al. Early detection of
cytomegalovirus (CMV) infection in bone marrow transplant patients by
reverse transcription-PCR for CMV spliced late gene UL21.5: a two site
evaluation. J Clin Virol . 2002(1-2);24:13-23. doi:
10.1016/s1386-6532(01)00209-8.
- Gerna G, Percivalle E, Baldanti F, et al. Human cytomegalovirus
replicates abortively in polymorphonuclear leukocytes after transfer
from infected endothelial cells via transient microfusion events.J Virol . 2000;74(12):5629-5638. doi:
10.1128/jvi.74.12.5629-5638.2000.
- Piccirilli G, Lanna F, Gabrielli L, et al. CMV-RNAemia as new marker
of active viral replication in transplant recipients. J Clin
Microbiol . 2024;62(5):e0163023. doi: 10.1128/jcm.01630-23.
- Blank A, Dekker CA. Ribonucleases of human serum, urine, cerebrospinal
fluid, and leukocytes. Activity staining following electrophoresis in
sodium dodecyl sulfate-polyacrylamide gels. Biochemistry .
1981;20(8):2261-2267. doi: 10.1021/bi00511a030.
- Girmenia C, Lazzarotto T, Bonifazi F, et al. Assessment and prevention
of cytomegalovirus infection in allogeneic hematopoietic stem cell
transplant and in solid organ transplant: A multidisciplinary
consensus conference by the Italian GITMO, SITO, and AMCLI societies.Clin Transplant . 2019;33(10):e13666. doi: 10.1111/ctr.13666.
TABLE 1. Characteristics of the patients analysed.